The Epidemiology of Psoriatic Arthritis Over Five Decades: A Population-Based Study.

The Epidemiology of Psoriatic Arthritis Over Five Decades: A Population-Based Study.
复制标题

DOI:
10.1002/art.41741
复制
发表时间:
2021-10
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
通讯作者:
Wright K
Wright K
中科院分区:
其他
文献类型:
--
作者:
Karmacharya P;Crowson CS;Bekele D;Achenbach SJ;Davis JM 3rd;Ogdie A;Duarte-García A;Ernste FC;Maradit-Kremers H;Tollefson MM;Wright K

文献摘要

参考文献

被引文献

相似文献

To determine the incidence of psoriatic arthritis (PsA) in a US population and describe trends in incidence and mortality over 5 decades. The previously identified population-based cohort of Olmsted County, Minnesota residents ≥18 years of age who fulfilled PsA criteria during 1970–1999 was extended to include patients with incident PsA in 2000–2017. Age- and sex-specific incidence rates and point prevalence, adjusted to 2010 US white population, were reported. There were 164 incident cases of PsA in 2000–17, with a mean age of 46.4 (SD=12.0) years and 47% females. The overall age- and sex-adjusted annual incidence of PsA per 100,000 population was 8.5 (95% CI 7.2–9.8), and higher in males (9.3, 95% CI 7.4–11.3) than females (7.7, 95% CI 5.9–9.4) in 2000–2017. Overall incidence was highest in the age range 40–59 years. The incidence rate was relatively stable in 2000–2017 with no evidence of increase overall or in males, but a modest increase of 3% per year in females, compared to 1970–1999 where a 4%/yr rise in incidence was observed. Point prevalence was 181.8 per 100,000 (95% CI 156.5–207.1) in 2015. The percentage of females increased from 39% in 1970–1999 and 41% in 2000–2009 to 54% in 2010–2017 (p=0.08). Overall survival in PsA did not differ from general population (SMR= 0.85, 95% CI 0.61–1.15). The incidence of PsA in this predominantly white US population was stable in 2000–2017 in contrast to previous years. However, an increasing proportion of females was found in this study.
DOI: 10.1136/annrheumdis-2016-209853
发表时间: 2017-04
影响因子: 27.4
作者:
Jadon DR;Sengupta R;Nightingale A;Lindsay M;Korendowych E;Robinson G;Jobling A;Shaddick G;Bi J;Winchester R;Giles JT;McHugh NJ
通讯作者: McHugh NJ
DOI: 10.1186/s13075-017-1497-4
发表时间: 2018-01-02
影响因子: 4.9
作者:
Eder L;Cohen AD;Feldhamer I;Greenberg-Dotan S;Batat E;Zisman D
通讯作者: Zisman D
DOI: 10.1002/acr.23743
发表时间: 2019-07-11
影响因子: 4.7
作者:
Eder, Lihi;Widdifield, Jessica;Tu, Karen
通讯作者: Tu, Karen
DOI: 10.3109/03009740903544212
发表时间: 2010-08-01
影响因子: 2.1
作者:
Hanova, P.;Pavelka, K.;Pikhart, H.
通讯作者: Pikhart, H.
DOI: 10.1093/rheumatology/kew502
发表时间: 2017-06-01
期刊: RHEUMATOLOGY
影响因子: 5.5
作者:
Ogdie, Alexis;Maliha, Samantha;Gelfand, Joel M.
通讯作者: Gelfand, Joel M.